Literature DB >> 9027271

Reliability of tuberculin skin test measurement.

J Pouchot1, A Grasland, C Collet, J Coste, J M Esdaile, P Vinceneux.   

Abstract

BACKGROUND: Important management decisions depend on results of the tuberculin skin test. However, the test is subject to several potential errors, and its reliability has not been adequately studied.
OBJECTIVE: To ascertain the reliability of tuberculin skin testing.
DESIGN: Cross-sectional study.
SETTING: University hospital. PARTICIPANTS: 96 persons who received a tuberculin skin test. MEASUREMENTS: Ballpoint-pen and palpation measures of induration.
RESULTS: Global intra- and interobserver reliability coefficients of the ballpoint-pen technique were high. Five percent of the time, however, a second measurement by the same observer could be at least 2.7 mm less to 3.0 mm more than the first measurement and the measurement from the second observer could be at least 3.4 mm less to 3.7 mm more than the measurement from the first observer. This could lead to the reclassification of a positive test result as negative or vice versa. The area of imprecision was 38% less broad for the ballpoint-pen technique than for the palpation technique.
CONCLUSION: Reading of tuberculin skin tests may frequently result in misclassifications when measurements are close to the cutoff point that separates negative from positive results.

Entities:  

Mesh:

Year:  1997        PMID: 9027271     DOI: 10.7326/0003-4819-126-3-199702010-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

1.  Optimism, goal conflict, and stressor-related immune change.

Authors:  S C Segerstrom
Journal:  J Behav Med       Date:  2001-10

2.  The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis.

Authors:  Benjamin D Fox; Mordechai R Kramer; Zohar Mor; Rachel Preiss; Victoria Rusanov; Leonardo Fuks; Nir Peled; Ilanit Haim; Meir Raz; David Shitrit
Journal:  Lung       Date:  2009-10-15       Impact factor: 2.584

3.  Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.

Authors:  Megha Saroha; M M A Faridi; Prerna Batra; Iqbal Kaur; D K Dewan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.

Authors:  Adithya Cattamanchi; Rachel Smith; Karen R Steingart; John Z Metcalfe; Anand Date; Courtney Coleman; Barbara J Marston; Laurence Huang; Philip C Hopewell; Madhukar Pai
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

5.  Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial.

Authors:  Niannian Ji; Neelam Mukherjee; Edwin E Morales; Maggie E Tomasini; Vincent Hurez; Tyler J Curiel; Getahun Abate; Dan F Hoft; Xiang-Ru Zhao; Jon Gelfond; Sourindra Maiti; Laurence J N Cooper; Robert S Svatek
Journal:  Oncoimmunology       Date:  2019-05-25       Impact factor: 8.110

6.  Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations.

Authors:  Karen A Heemstra; Ailko W J Bossink; Roan Spermon; John J M Bouwman; Robert van der Kieft; Steven F T Thijsen
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

Review 7.  Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis.

Authors:  Qiaoling Ruan; Shu Zhang; Jingwen Ai; Lingyun Shao; Wenhong Zhang
Journal:  Clin Rheumatol       Date:  2014-11-07       Impact factor: 2.980

8.  Should interferon gamma release assays become the standard method for screening patients for Mycobacterium tuberculosis infections in the United States?

Authors:  Thomas S Alexander; Melissa B Miller; Peter Gilligan
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

9.  A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.

Authors:  Arjan J Kwakernaak; Pieternella M Houtman; Jan F L Weel; Johanna P L Spoorenberg; Tim L T A Jansen
Journal:  Clin Rheumatol       Date:  2010-08-25       Impact factor: 2.980

10.  Current management options for latent tuberculosis: a review.

Authors:  Brianna L Norton; David P Holland
Journal:  Infect Drug Resist       Date:  2012-11-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.